June 2019 | AIChE

Other Sites & Tools

Technical Groups

You are here

June 2019

This Week in Chemical Engineering - Food, Pharmaceutical & Bioengineering Spotlight: June 24, 2019

Don't miss out on the latest business and technology news for chemical engineers, featuring select items in relation to Food, Pharmaceuticals & Bioengineering!

Dr. Alexander Titus

Dr. Alexander Titus is currently the Assistant Director (AD) for Biotechnology within the Office of the Under Secretary of Defense for Research & Engineering (OUSD(R&E)). As the AD for Biotechnology, Dr. Titus is the technical and oversight lead for all relevant research and engineering matters across the biotechnology portfolio, and is responsible for developing the department’s biotechnology roadmap.

Prior to OUSD(R&E), Dr. Titus was a management consultant at McKinsey & Company focused on working with the defense & security communities on organizational...Read more

Richmond Flying Squirrels baseball

June 21, 2019
Wednesday, July 31, 2019,
6:30pm to 10:00pm
EDT
Join the Tidewater Virginia AIChE local section to see the Richmond Flying Squirrels in action against the Portland Sea Dogs, the AA affiliate of the Boston Red Sox at the Diamond on the Boulevard in Richmond. Our tickets are in section 103, on the right field side, just past the Flying Squirrels...Read more

Ron Milo

Prof. Ron Milo earned a BSc in Physics and Mathematics at the Hebrew University of Jerusalem and a PhD in Biological Physics at the Weizmann Institute of Science. He was the first fellow in Systems Biology at Harvard Medical School before joining the Department of Plant and Environmental Sciences at the Weizmann Institute.

Ron brings the tools of systems biology to bear on the challenges of sustainability.

His scientific awards include the GE & Science Prize for Young Life Scientists, the John F. Kennedy Prize and the D.N. Chorafas International PhD award. He...Read more

Matt Helgeson

Matt Helgeson is an Associate Professor of Chemical Engineering at UC Santa Barbara, where he is also a faculty member and Interdisciplinary Research Group co-leader of the Materials Research Laboratory (an NSF MRSEC). He received his B.S. in Chemical Engineering at Carnegie Mellon University in 2004, and his Ph.D. in Chemical Engineering at the University of Delaware in 2009. He performed postdoctoral research in the MIT-Novartis Center for Continuous Manufacturing before joining the faculty at UCSB. Prof. Helgeson’s research focuses on design, formulation and processing of complex fluids...Read more

Lili Yang

Dr. Lili Yang received her Ph.D. degree in Biology from the California Institute of Technology (Caltech) in 2004, trained at the Laboratory of David Baltimore. She led the Engineering Immunity Program at Caltech from 2004 to 2012, developing immunotherapies for cancer and HIV/AIDS. She joined the University of California, Los Angeles (UCLA) as an Assistant Professor in 2013. Her laboratory at UCLA studies tumor immunology and cancer immunotherapy, with a special focus on stem cell-based and gene-engineered immunotherapy for cancer. Her work resulted in 29 publications, 10 patents, and 2...Read more

Uwe Sauer

As a trained microbiologist and with a postdoc in metabolic engineering, Uwe’s research as a PI and since 2006 as a professor for systems biology at the ETH Zurich focused on fundamental questions related to microbial metabolism.Read more

Robert Kiss

Bob Kiss is Vice President of Process and Analytical Development at Sutro Biopharma, a company developing novel human biotherapeutics. He has more than 27 years of industrial biotechnology experience. Prior to Sutro, Bob spent 24 years at Genentech, where his final role was Senior Director and Distinguished Engineer leading cell culture development. His career focus areas have included control of product quality, barriers to adventitious agent contamination, and process scaleup and transfer for cell culture and fermentation processes. He currently focuses on industrializing the Sutro cell-...Read more

Gregory Frank

A biochemical engineer with over 20 years experience in development ranging from early stages through commercial launch of therapeutics and technologies at both small biopharmaceutical and large pharmaceutical companies. Especially adept at finding cross-functional, phase appropriate and innovative solutions to challenges in both cell culture and downstream processes and facilities associated with moving discovery concepts from pre-clinical through commercialized therapeutics.

A leader who builds high performing teams focused on timely, cost effective solutions for moving projects...Read more

Climate Solutions

Climate change is challenging industry and will continue to do so until mitigation, adaptation and resiliency solutions become commercially viable.

Pages